Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02769286
What this trial is testing

Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA

Who this might be right for
Lung NeoplasmsEGFR Gene Mutations
Chonnam National University Hospital 38
Large-scale testing (Phase 3)Study completedNCT01707966
What this trial is testing

Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 47
Large-scale testing (Phase 3)Study completedNCT01909453
What this trial is testing

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

Who this might be right for
Melanoma
Pfizer 921
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Early research (Phase 1)Looking for participantsNCT07145177
What this trial is testing

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer
University of California, San Francisco 30
Post-approval studies (Phase 4)Study completedNCT00558077
What this trial is testing

Second-Line Treatments for Anovulatory Infertility in PCOS Patients

Who this might be right for
Polycystic Ovary SyndromeInfertilityAnovulation
University Magna Graecia 50
Testing effectiveness (Phase 2)Looking for participantsNCT06067503
What this trial is testing

Biomarkers to Detect Endocrine Therapy Resistance

Who this might be right for
Metastatic CancerBreast CancerLobular Breast Carcinoma
University of Wisconsin, Madison 8
Large-scale testing (Phase 3)Study completedNCT01824342
What this trial is testing

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Who this might be right for
Castrate-resistant Prostate Cancer
Amgen 18
Testing effectiveness (Phase 2)Looking for participantsNCT04038502
What this trial is testing

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate CancerBARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2RAD51B, RAD51C, RAD51D, or RAD54L Mutations
VA Office of Research and Development 100
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 219
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Large-scale testing (Phase 3)Looking for participantsNCT06925737
What this trial is testing

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Who this might be right for
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC 1,440
Testing effectiveness (Phase 2)UnknownNCT00003253
What this trial is testing

Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Oncotech 100
Large-scale testing (Phase 3)Study completedNCT03834493
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,244
Post-approval studies (Phase 4)Study completedNCT01506947
What this trial is testing

A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients

Who this might be right for
Moderate to Severe Secondary HyperparathyroidismStage 5 Chronic Kidney Diseases
AbbVie (prior sponsor, Abbott) 65
Large-scale testing (Phase 3)Study completedNCT00128310
What this trial is testing

Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT07553988
What this trial is testing

A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
R-Pharm International, LLC 120
Testing effectiveness (Phase 2)Ended earlyNCT01681368
What this trial is testing

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms
National Cancer Institute (NCI) 11
Early research (Phase 1)Ended earlyNCT05241613
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 28
Early research (Phase 1)Looking for participantsNCT04150042
What this trial is testing

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Who this might be right for
Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more
General Oncology, Inc. 24
Next Page